Calithera Biosciences, Inc. Gains 42.77%

Fri, May 13, 2022 at 05:30 PM
Calithera Biosciences, Inc. Gains 42.77%

Calithera Biosciences, Inc. (CALA:NASDAQ) rocketted at $0.23, representing a gain of 42.8%. On Thu, May 12, 2022, CALA:NASDAQ hit a New 2-Week Intraday Low of $0.15. The stock got featured on our News Catalysts scanner on Tue, May 10, 2022 at 05:28 PM in the 'EARNINGS' category. From Thu, Apr 28, 2022, the stock recorded 20.00% Up Days and 27.27% Green Days

The stock spiked on Thu, Apr 21, 2022 at $0.4 with a volume of 23M+.

About Calithera Biosciences, Inc. (CALA:NASDAQ)

Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.